There are several candidate genes for modelling regional vulnerability in AD, most notably the microtubule association protein tau (MAPT), as a proxy for relative baseline tau vulnerability [53] and apolipoprotein-E (APOE) for those patients with the APOEε4 mutation [29, 54, 55]. The gene discussed is MAPT; the disease is Alzheimer disease.